Caplin Steriles Ltd receives approval from Brazil's ANVISA

Caplin Steriles Ltd, a subsidiary of Caplin Point Laboratories Ltd, has received approval from Brazil's National Health Surveillance Agency ANVISA (Agência Nacional de Vigilância Sanitária) for its sterile injectable manufacturing site near Chennai, Tamilnadu. The approval grants access to the company to register and market its products in Brazil, the largest Pharmaceutical market in Latin America.

Mr. C. C. Paarthipan, Chairman of Caplin Point Laboratories Limited commented "Brazil is an important target for Caplin Steriles' mid to long term expansion plans. As a first step, we will focus on extending our US approved products for Brazil."

Shares of Caplin Point Laboratories Ltd. was last trading in BSE at Rs. 803 as compared to the previous close of Rs. 821.4. The total number of shares traded during the day was 31072 in over 2528 trades.

The stock hit an intraday high of Rs. 836.6 and intraday low of 801. The net turnover during the day was Rs. 25519241.

Source : Equity Bulls

Keywords